View Financial HealthHealing 배당 및 자사주 매입배당 기준 점검 0/6Healing 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2024, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 18+ 1 more updatethe Healing Company Inc. Announces Resignation of Ameeth Sankaran from BoardThe Healing Company Inc. announced on November 14, 2023, Ameeth Sankaran notified the Company of his decision to resign from the Company’s Board effective immediately. Mr. Sankaran’s resignation did not result from any disagreement with the Company on any matter related to the Company’s operations, policies or practices.공시 • Nov 15The Healing Company Inc. announced delayed 10-Q filingOn 11/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 28The Healing Company and Your Super Announces Your Super's Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial ParticipantsThe Healing Company and its portfolio company Your Super announced Your Super's superfood blend, Moon Balance, is now clinically proven to reduce painful periods and associated menstrual symptoms. 80% of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved. With more than 75% of women experiencing PMS, Your Super commissioned Citruslabs, one of the leading clinical research organizations in the United States, to conduct a preliminary study focused on testing Moon Balance's effectiveness in improving common menstrual cycle issues. Topline results from the clinical trial include: Reduced Pain & Dis comfort: Participants reported their menstrual cramps were less severe (by 33%), bloating symptoms improved (by 30%) and they ultimately experienced fewer days of PMS symptoms overall. More Balance: 72% reported fewer mood swings, and 69% shared they felt calmer and less stressed. Improved Sleep Quality: 66% experienced better quality sleep and 59% slept longer. Increased Productivity: 69% canceled fewer plans, missed fewer work hours and were more productive. Retailing at $29.99 for a month's supply, Your Super's Moon Balance superfood blend was mindfully formulated for women with only six nourishing ingredients and no artificial sweeteners, fillers or gums. With more than three thousand five-star customer reviews, Moon Balance is consistently one of Your Super's top rated and highest selling products.공시 • Jul 18The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar.The Healing Company Inc. (OTCPK:HLCO) entered into a definitive agreement to acquire Northern Pacific Kaviar on June 29, 2023. As consideration for the transaction, The Healing Company will issue to the shareholders of Northern Pacific Kaviar: (i) 1.6666666 common shares of the Company for each Northern Pacific Kaviar Share, for an aggregate of 16,666,666 Common Shares, and (ii) 1.6666666 warrants to purchase Common Shares for each Northern Pacific Kaviar Warrant, for an aggregate of 16,666,666 Replacement Warrants. The Acquisition is subject to a number of conditions to close, including the approval of the CSE, and it is anticipated that the Acquisition will close in the coming weeks.The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar on July 17, 2023.공시 • Jul 09The Healing Company Inc. Announces Board ChangesOn May 26, 2023, the Board of Directors of The Healing Company Inc. elected Ameeth Sankaran to fill the open position on the Board created by the resignation of Poonacha Machaiah from the Board on May 2, 2023. Since January 2017, Mr. Sankaran has served as Chief Executive Officer of Religion of Sports, an Emmy Award winning Media company co-founded by Tom Brady, Michael Strahan and Gotham Chopra, built on the thesis that sports are religion. The company produces content focused on a single narrative of ‘Why Sports Matter’ to explore themes such as, for example, greatness and human potential. Since 2017, Religion of Sports has produced content across media, from short-form video to audio to feature films and has won multiple awards including a Sports Emmy. Ameeth is an Executive Producer of Tom vs. Time, Greatness Code, Stephen vs. the Game, Man in the Arena, and the Crushed podcast among others. Mr. Sankaran also served as an advisor to 2M Companies LLC (“2M”), from 2017 to 2019 and was a Partner at 2M from 2013 to 2016. Prior to that, Ameeth was a Principal at The Boston Consulting Group where he worked from 2005 to 2013. Mr. Sankaran earned a Bachelor of Science degree in Mechanical Engineering from The University of Texas at Austin in 1999 and an MBA in Finance and Management from Columbia Business School in 2005. Ameeth has been engaged for more than 15 years as a strategy consultant and a private equity investor.공시 • Jul 07The Healing Company Inc. announced that it has received $7 million in funding from Burman Family Office and other investorsThe Healing Company Inc. announced a private placement and received up to $7 million on July 6, 2023. The transaction included participation from strategic partners including the investment office of the Burman family and esteemed German family office of Stephan and Ingvild Goetz (Munich). Including previously financing, this brings total raised and committed equity funding to up to $17 million, alongside the $150 million credit facility supporting future acquisitions.공시 • May 16The Healing Company Inc. announced delayed 10-Q filingOn 05/15/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 16The Healing Company Inc. announced delayed 10-Q filingOn 11/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Oct 29The Healing Company Inc. announced that it has received $1 million in fundingOn October 28, 2022, The Healing Company Inc. closed the transaction. The transaction included participation from 2 investors.공시 • Sep 29The Healing Company Inc. announced delayed annual 10-K filingOn 09/28/2022, The Healing Company Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Jun 15+ 1 more updateThe Healing Company Inc. Announces Executive ChangesOn June 6, 2022, The Healing Company Inc. (the “Company”) received the resignation of Mr. Lee Larson Elmore as Secretary, Treasurer and Chief Financial Officer of the Company. Mr. Elmore did not resign due to any dispute or disagreement with the Company or its practices. On June 6, 2022, the Company received a consent to act as Secretary, Treasurer and Chief Financial Officer of the Company from Amit Kapur. Further, concurrently, the board of directors of the Company (the “Board”) approved Mr. Kapur’s offer letter dated June 2, 2022 (the “Offer Letter”) and appointed Mr. Kapur Secretary, Treasurer and Chief Financial Officer of the Company. Under the terms of the Offer Letter to commence June 6, 2022 (the “Start Date”), Mr. Kapur will be paid an annual base salary of $300,000 subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law. Further, Mr. Kapur shall have the right to receive an annual bonus as determined by the Board and based on Company results and the achievement of applicable performance goals established by the Board. Additionally, Mr. Kapur shall receive an option to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Company common stock in accordance with the terms of the Company’s 2022 Omnibus Equity Incentive Plan and its standard option agreement, once approved by the Board (the “Option”). The Option shall be exercisable at the fair market value of the common stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option shall vest ratably over a four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date). The employment offer and acceptance is for no fixed term and can be terminated by either party with or without cause, and with or without notice and for any reason or no particular reason. Mr. Kapur will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives and he will be subject to non-competition and non-solicitation provisions. If Mr. Kapur’s employment with the Company is involuntarily terminated for reasons other than Cause (as defined in the Offer Letter) or a breach by him of the terms and conditions of the Offer Letter (including, but not limited to, a breach of any of the representations contained therein), he shall be entitled to continue to receive his base salary through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date. Mr. Kapur has more than 20 years of chief financial leadership positions with an array of consumer goods, venture capital, private equity and consulting experience. He is a detailed-oriented, driven, executive with an extremely strong track record of leadership, business development, revenue generation, communication, project management, financial control, operations, IT, capital markets, and other corporate activities. He possesses exceptional analytical skills, with the ability to examine and understand business needs and deliver comprehensive reports for external groups while exceeding rigorous expectations. His academic credentials include a fundamental background in valuation, analytics, and research. His skills include the evaluation of new ventures and investment opportunities. He has a large network of associates which includes CEO/CFO/COOs, high net worth investors, entrepreneurs, and senior management in various industries. Mr. Kapur is joining the Company after spending more than three years (from February 2019) with The Anthos Group, a company with a market cap of $100 million, where he served as Chief Financial Officer and Chief Operating Officer of Farms. During his term at The Anthos Group, he undertook various duties for that company including overseeing and developing policies whereby the company was able to reduce its G&A expenses by 40% and reduce capital expenditures while growing revenues. He also participated in the closing of financings for that company and the structuring and closing of various joint ventures. In 2004, Mr. Kapur founded a real estate private equity fund and he still sits as Chairman of the Board of that company. Mr. Kapur has had varied positions throughout his career, as a senior auditor for a large accounting firm prior to 2004 and from June 2017 to March 2019, he was a member and executive at Toptal, LLC, a company providing an exclusive network of the top freelance software developers, designers, finance experts product managers and project managers where he was assigned various projects over a broad spectrum of companies. Educated at Northwestern? Kellogg School of Management, he has a Master’s of Business Administration with a focus on finance, entrepreneurship and marketing and also holds degrees from the University of Illinois at Chicago (UIC) (Bachelor of Science, Accounting) and the University of Delhi (Bachelor of Science, Business Commerce, Honors). Mr. Kapur also sits on the Board of Directors of Superfyt and is a member of CFOrward and a contributor to Think Deal Training. He is a Board member of Found Chicago Dog Training and Rescue Home, the Vice Chairman of Dreams for Kids, the Founder of Kapur Christmas Drive which annually feeds and clothes hundreds of homeless across Chicago and a Mentor of the Boys and Girls Club.공시 • May 17The Healing Company Inc. announced delayed 10-Q filingOn 05/16/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Mar 29The Healing Company Inc. Appoints Kay Koplovitz to the Board of Directors and as Chairman of the Board Effective April 1, 2022The Healing Company Inc. announced on March 23, 2022, the Board of Directors approved a Board Service Agreement and appointed Kay Koplovitz to the Board of Directors and as Chairman of the Board effective April 1, 2022. Kay Koplovitz is co-Founder & Chairman of Springboard Enterprises. Ms. Koplovitz is the founder and former CEO of USA Networks, the SyFy Channel. Ms. Koplovitz currently serves on the Boards of Athena Consumer Acquisition Corp. SPAC (ACAQ) and private company Veniam.공시 • Feb 16The Healing Company Inc. announced delayed 10-Q filingOn 02/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 HLCO 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: HLCO 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Healing 배당 수익률 vs 시장HLCO의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (HLCO)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Personal Products)3.4%분석가 예측 (HLCO) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 HLCO 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 HLCO 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 HLCO 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: HLCO 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/04/01 14:40종가2026/01/02 00:00수익2023/09/30연간 수익2023/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스The Healing Company Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2024, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 18+ 1 more updatethe Healing Company Inc. Announces Resignation of Ameeth Sankaran from BoardThe Healing Company Inc. announced on November 14, 2023, Ameeth Sankaran notified the Company of his decision to resign from the Company’s Board effective immediately. Mr. Sankaran’s resignation did not result from any disagreement with the Company on any matter related to the Company’s operations, policies or practices.
공시 • Nov 15The Healing Company Inc. announced delayed 10-Q filingOn 11/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 28The Healing Company and Your Super Announces Your Super's Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial ParticipantsThe Healing Company and its portfolio company Your Super announced Your Super's superfood blend, Moon Balance, is now clinically proven to reduce painful periods and associated menstrual symptoms. 80% of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved. With more than 75% of women experiencing PMS, Your Super commissioned Citruslabs, one of the leading clinical research organizations in the United States, to conduct a preliminary study focused on testing Moon Balance's effectiveness in improving common menstrual cycle issues. Topline results from the clinical trial include: Reduced Pain & Dis comfort: Participants reported their menstrual cramps were less severe (by 33%), bloating symptoms improved (by 30%) and they ultimately experienced fewer days of PMS symptoms overall. More Balance: 72% reported fewer mood swings, and 69% shared they felt calmer and less stressed. Improved Sleep Quality: 66% experienced better quality sleep and 59% slept longer. Increased Productivity: 69% canceled fewer plans, missed fewer work hours and were more productive. Retailing at $29.99 for a month's supply, Your Super's Moon Balance superfood blend was mindfully formulated for women with only six nourishing ingredients and no artificial sweeteners, fillers or gums. With more than three thousand five-star customer reviews, Moon Balance is consistently one of Your Super's top rated and highest selling products.
공시 • Jul 18The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar.The Healing Company Inc. (OTCPK:HLCO) entered into a definitive agreement to acquire Northern Pacific Kaviar on June 29, 2023. As consideration for the transaction, The Healing Company will issue to the shareholders of Northern Pacific Kaviar: (i) 1.6666666 common shares of the Company for each Northern Pacific Kaviar Share, for an aggregate of 16,666,666 Common Shares, and (ii) 1.6666666 warrants to purchase Common Shares for each Northern Pacific Kaviar Warrant, for an aggregate of 16,666,666 Replacement Warrants. The Acquisition is subject to a number of conditions to close, including the approval of the CSE, and it is anticipated that the Acquisition will close in the coming weeks.The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar on July 17, 2023.
공시 • Jul 09The Healing Company Inc. Announces Board ChangesOn May 26, 2023, the Board of Directors of The Healing Company Inc. elected Ameeth Sankaran to fill the open position on the Board created by the resignation of Poonacha Machaiah from the Board on May 2, 2023. Since January 2017, Mr. Sankaran has served as Chief Executive Officer of Religion of Sports, an Emmy Award winning Media company co-founded by Tom Brady, Michael Strahan and Gotham Chopra, built on the thesis that sports are religion. The company produces content focused on a single narrative of ‘Why Sports Matter’ to explore themes such as, for example, greatness and human potential. Since 2017, Religion of Sports has produced content across media, from short-form video to audio to feature films and has won multiple awards including a Sports Emmy. Ameeth is an Executive Producer of Tom vs. Time, Greatness Code, Stephen vs. the Game, Man in the Arena, and the Crushed podcast among others. Mr. Sankaran also served as an advisor to 2M Companies LLC (“2M”), from 2017 to 2019 and was a Partner at 2M from 2013 to 2016. Prior to that, Ameeth was a Principal at The Boston Consulting Group where he worked from 2005 to 2013. Mr. Sankaran earned a Bachelor of Science degree in Mechanical Engineering from The University of Texas at Austin in 1999 and an MBA in Finance and Management from Columbia Business School in 2005. Ameeth has been engaged for more than 15 years as a strategy consultant and a private equity investor.
공시 • Jul 07The Healing Company Inc. announced that it has received $7 million in funding from Burman Family Office and other investorsThe Healing Company Inc. announced a private placement and received up to $7 million on July 6, 2023. The transaction included participation from strategic partners including the investment office of the Burman family and esteemed German family office of Stephan and Ingvild Goetz (Munich). Including previously financing, this brings total raised and committed equity funding to up to $17 million, alongside the $150 million credit facility supporting future acquisitions.
공시 • May 16The Healing Company Inc. announced delayed 10-Q filingOn 05/15/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 16The Healing Company Inc. announced delayed 10-Q filingOn 11/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Oct 29The Healing Company Inc. announced that it has received $1 million in fundingOn October 28, 2022, The Healing Company Inc. closed the transaction. The transaction included participation from 2 investors.
공시 • Sep 29The Healing Company Inc. announced delayed annual 10-K filingOn 09/28/2022, The Healing Company Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Jun 15+ 1 more updateThe Healing Company Inc. Announces Executive ChangesOn June 6, 2022, The Healing Company Inc. (the “Company”) received the resignation of Mr. Lee Larson Elmore as Secretary, Treasurer and Chief Financial Officer of the Company. Mr. Elmore did not resign due to any dispute or disagreement with the Company or its practices. On June 6, 2022, the Company received a consent to act as Secretary, Treasurer and Chief Financial Officer of the Company from Amit Kapur. Further, concurrently, the board of directors of the Company (the “Board”) approved Mr. Kapur’s offer letter dated June 2, 2022 (the “Offer Letter”) and appointed Mr. Kapur Secretary, Treasurer and Chief Financial Officer of the Company. Under the terms of the Offer Letter to commence June 6, 2022 (the “Start Date”), Mr. Kapur will be paid an annual base salary of $300,000 subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law. Further, Mr. Kapur shall have the right to receive an annual bonus as determined by the Board and based on Company results and the achievement of applicable performance goals established by the Board. Additionally, Mr. Kapur shall receive an option to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Company common stock in accordance with the terms of the Company’s 2022 Omnibus Equity Incentive Plan and its standard option agreement, once approved by the Board (the “Option”). The Option shall be exercisable at the fair market value of the common stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option shall vest ratably over a four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date). The employment offer and acceptance is for no fixed term and can be terminated by either party with or without cause, and with or without notice and for any reason or no particular reason. Mr. Kapur will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives and he will be subject to non-competition and non-solicitation provisions. If Mr. Kapur’s employment with the Company is involuntarily terminated for reasons other than Cause (as defined in the Offer Letter) or a breach by him of the terms and conditions of the Offer Letter (including, but not limited to, a breach of any of the representations contained therein), he shall be entitled to continue to receive his base salary through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date. Mr. Kapur has more than 20 years of chief financial leadership positions with an array of consumer goods, venture capital, private equity and consulting experience. He is a detailed-oriented, driven, executive with an extremely strong track record of leadership, business development, revenue generation, communication, project management, financial control, operations, IT, capital markets, and other corporate activities. He possesses exceptional analytical skills, with the ability to examine and understand business needs and deliver comprehensive reports for external groups while exceeding rigorous expectations. His academic credentials include a fundamental background in valuation, analytics, and research. His skills include the evaluation of new ventures and investment opportunities. He has a large network of associates which includes CEO/CFO/COOs, high net worth investors, entrepreneurs, and senior management in various industries. Mr. Kapur is joining the Company after spending more than three years (from February 2019) with The Anthos Group, a company with a market cap of $100 million, where he served as Chief Financial Officer and Chief Operating Officer of Farms. During his term at The Anthos Group, he undertook various duties for that company including overseeing and developing policies whereby the company was able to reduce its G&A expenses by 40% and reduce capital expenditures while growing revenues. He also participated in the closing of financings for that company and the structuring and closing of various joint ventures. In 2004, Mr. Kapur founded a real estate private equity fund and he still sits as Chairman of the Board of that company. Mr. Kapur has had varied positions throughout his career, as a senior auditor for a large accounting firm prior to 2004 and from June 2017 to March 2019, he was a member and executive at Toptal, LLC, a company providing an exclusive network of the top freelance software developers, designers, finance experts product managers and project managers where he was assigned various projects over a broad spectrum of companies. Educated at Northwestern? Kellogg School of Management, he has a Master’s of Business Administration with a focus on finance, entrepreneurship and marketing and also holds degrees from the University of Illinois at Chicago (UIC) (Bachelor of Science, Accounting) and the University of Delhi (Bachelor of Science, Business Commerce, Honors). Mr. Kapur also sits on the Board of Directors of Superfyt and is a member of CFOrward and a contributor to Think Deal Training. He is a Board member of Found Chicago Dog Training and Rescue Home, the Vice Chairman of Dreams for Kids, the Founder of Kapur Christmas Drive which annually feeds and clothes hundreds of homeless across Chicago and a Mentor of the Boys and Girls Club.
공시 • May 17The Healing Company Inc. announced delayed 10-Q filingOn 05/16/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Mar 29The Healing Company Inc. Appoints Kay Koplovitz to the Board of Directors and as Chairman of the Board Effective April 1, 2022The Healing Company Inc. announced on March 23, 2022, the Board of Directors approved a Board Service Agreement and appointed Kay Koplovitz to the Board of Directors and as Chairman of the Board effective April 1, 2022. Kay Koplovitz is co-Founder & Chairman of Springboard Enterprises. Ms. Koplovitz is the founder and former CEO of USA Networks, the SyFy Channel. Ms. Koplovitz currently serves on the Boards of Athena Consumer Acquisition Corp. SPAC (ACAQ) and private company Veniam.
공시 • Feb 16The Healing Company Inc. announced delayed 10-Q filingOn 02/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.